FDA Inspection 1341150 — Novo Nordisk A/S - KV

Novo Nordisk A/S - KV — FEI 3015545250

The FDA completed an inspection of Novo Nordisk A/S - KV on May 2, 2024 in Varlose. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.